Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GENB Generate Biomedicines

交易中 08-14 10:53:35 EDT

14.97

-0.06

-0.39%

最高15.13	最低14.56	成交量4.34万
今开14.99	昨收15.03	日振幅3.78%
总市值19.19亿	流通市值9.03亿	总股本1.28亿
成交额64.65万	换手率0.07%	流通股本6,029万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":14.9712,"timestamp":1786719196224,"preClose":15.03,"halted":0,"volume":43431,"delay":0,"changeRate":-0.003912175648702578,"floatShares":60288200,"shares":128192484,"eps":-1.7389085,"marketStatus":"交易中","change":-0.0588,"latestTime":"08-14 10:53:35 EDT","open":14.99,"high":15.13,"low":14.5619,"amount":646501.922475,"amplitude":0.037798,"askPrice":15.09,"askSize":100,"bidPrice":14.98,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-1.7389085,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786737600000},"marketStatusCode":2,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":15.03,"preHourTrading":{"tag":"盘前","latestPrice":15,"preClose":15.03,"latestTime":"09:26 EDT","volume":373,"amount":5597.561391,"timestamp":1786713973592,"change":-0.03,"changeRate":-0.001996,"amplitude":0.030605},"postHourTrading":{"tag":"盘后","latestPrice":15.352,"preClose":15.03,"latestTime":"19:48 EDT","volume":1170,"amount":17710.1285,"timestamp":1786664908729,"change":0.322,"changeRate":0.021424,"amplitude":0.021424},"volumeRatio":0.369709},"requestUrl":"/m/hq/s/GENB/wiki","defaultTab":"wiki","newsList":[{"id":"1196527286","title":"Generate Biomedicines：现有现金、现金等价物及有价证券足以支撑运营计划至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1196527286","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196527286?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:13","pubTimestamp":1786014817,"startTime":"0","endTime":"0","summary":"Generate Biomedicines 宣布，公司当前持有的现金、现金等价物以及有价证券，已足够支持其现有运营计划，直至2028年上半年。这一资金储备状况，为公司未来的研发与业务拓展提供了坚实的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176782309","title":"Generate Biomedicines预计现有资金可支持运营至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1176782309","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176782309?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:21","pubTimestamp":1778149271,"startTime":"0","endTime":"0","summary":"Generate Biomedicines公司近日表示，其现有的现金、现金等价物及有价证券储备预计足以支撑公司日常运营持续至2028年上半年。这一资金规划为企业的长期发展战略提供了稳定的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170560375","title":"摩根士丹利首予Generate Biomedicines增持评级 目标价20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170560375","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170560375?lang=zh_cn&edition=full","pubTime":"2026-03-24 20:45","pubTimestamp":1774356311,"startTime":"0","endTime":"0","summary":"摩根士丹利宣布，首次覆盖生物医药公司Generate Biomedicines，并给予“增持”评级。该机构同时设定了20美元的目标股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184653688","title":"Piper Sandler首予Generate Biomedicines增持评级 目标价24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184653688","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184653688?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:44","pubTimestamp":1774338251,"startTime":"0","endTime":"0","summary":"Piper Sandler近日宣布，正式启动对生物医药公司Generate Biomedicines的研究覆盖，并给予其\"增持\"评级。该机构同时设定了24美元的目标股价，显示出对该公司未来增长潜力的积极预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165464916","title":"异动解读 | 市场波动引发投资者谨慎，Generate Biomedicines盘中大跌9.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165464916","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165464916?lang=zh_cn&edition=full","pubTime":"2026-02-28 02:10","pubTimestamp":1772215808,"startTime":"0","endTime":"0","summary":"Generate Biomedicines（GENB）今日盘中股价大跌9.38%，引起了市场的广泛关注。消息面上，由于挥之不去的市场波动使投资者对新上市企业保持谨慎，导致该股在首次上市时股价承压。根据相关报道，市场整体波动性使得投资者风险偏好降低，对新上市的股票采取更为保守的态度，从而影响了Generate Biomedicines的股价表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614889265","title":"AI制药企业Generate Biomedicines(GENB.US)IPO定价16美元/股 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2614889265","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614889265?lang=zh_cn&edition=full","pubTime":"2026-02-27 14:50","pubTimestamp":1772175025,"startTime":"0","endTime":"0","summary":"专注于免疫学与肿瘤学领域的AI药物研发公司Generate Biomedicines(GENB.US)正式公布美股IPO发行价。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260227/20260227145043_27698.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260227/20260227145043_27698.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI制药企业Generate Biomedicines(GENB.US)IPO定价16美元/股 今晚登陆纳斯达克","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4007","BK1574","BK1191","BK1147","GENB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.generatebiomedicines.com","stockEarnings":[{"period":"1week","weight":0.0821},{"period":"1month","weight":0.0577},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0606},{"period":"ytd","weight":-0.0606}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Generate Biomedicines, Inc.于2018年8月根据特拉华州法律成立。作为一家临床阶段的生成生物学公司，该公司首创了名为Generate Platform的人工智能驱动的生物技术平台，该平台将计算模型与可扩展的生物硬件相结合，以设计和开发新型治疗性蛋白质。其最先进的候选药物GB-0895是一种计算工程抗TSLP单克隆抗体，目前正处于严重哮喘的关键3期试验中。该平台的能力已通过在2026年将另外两个肿瘤候选药物推向1期试验而得到进一步证明。","exchange":"NASDAQ","name":"Generate Biomedicines","nameEN":"Generate Biomedicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Generate Biomedicines(GENB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Generate Biomedicines,GENB,Generate Biomedicines股票,Generate Biomedicines股票老虎,Generate Biomedicines股票老虎国际,Generate Biomedicines行情,Generate Biomedicines股票行情,Generate Biomedicines股价,Generate Biomedicines股市,Generate Biomedicines股票价格,Generate Biomedicines股票交易,Generate Biomedicines股票购买,Generate Biomedicines股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Generate Biomedicines(GENB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}